Oxime-20
General
Type : Pyridinium, Oxime
Chemical_Nomenclature : (NE)-N-[[1-[4-(4-phenylmethoxyphenoxy)butyl]pyridin-1-ium-4-yl]methylidene]hydroxylamine
Canonical SMILES : C1=CC=C(C=C1)COC2=CC=C(C=C2)OCCCC[N+]3=CC=C(C=C3)C=NO
InChI : InChI=1S\/C23H24N2O3\/c26-24-18-20-12-15-25(16-13-20)14-4-5-17-27-22-8-10-23(11-9-22)28-19-21-6-2-1-3-7-21\/h1-3,6-13,15-16,18H,4-5,14,17,19H2\/p+1
InChIKey : VIIFYULPLCLNLN-UHFFFAOYSA-O
Other name(s) :
MW : 377.5
Formula : C23H25N2O3+
CAS_number :
PubChem : 135993293
UniChem : VIIFYULPLCLNLN-UHFFFAOYSA-O
Target
Structure : No structure
Families : No family
References (3)
| Title : Pharmacokinetics of three novel pyridinium aldoxime acetylcholinesterase reactivators in female rats - Backer_2022_Toxicol.Appl.Pharmacol_446_116046 |
| Author(s) : Backer BS , Meek EC , Ross MK , Chambers JE |
| Ref : Toxicol Appl Pharmacol , 446 :116046 , 2022 |
| Abstract : |
| PubMedSearch : Backer_2022_Toxicol.Appl.Pharmacol_446_116046 |
| PubMedID: 35550885 |
| Title : Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates - Chambers_2020_Ann.N.Y.Acad.Sci__ |
| Author(s) : Chambers JE , Meek EC |
| Ref : Annals of the New York Academy of Sciences , : , 2020 |
| Abstract : |
| PubMedSearch : Chambers_2020_Ann.N.Y.Acad.Sci__ |
| PubMedID: 32319115 |
| Title : Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates - Chambers_2013_Chem.Biol.Interact_203_135 |
| Author(s) : Chambers JE , Chambers HW , Meek EC , Pringle RB |
| Ref : Chemico-Biological Interactions , 203 :135 , 2013 |
| Abstract : |
| PubMedSearch : Chambers_2013_Chem.Biol.Interact_203_135 |
| PubMedID: 23123249 |